Nalmefene for reducing alcohol consumption in people with alcohol dependence - guidance (TA325)

Source:
National Institute for Health and Care Excellence - NICE
Publication date:
26 November 2014

Abstract

Evidence-based recommendations on nalmefene (Selincro) for reducing alcohol consumption in adults with alcohol dependence. 

Guidance development process 

How we develop NICE technology appraisal guidance 

Is this guidance up to date?

We reviewed the evidence in March 2018. We found nothing new that affects the recommendations in this guidance.

Next review: This guidance will be reviewed if there is new evidence that is likely to affect the recommendations.